University of California, San Diego
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of California, San Diego sits in the top decile of US sponsors by registered trial count (#43 of 15,742 sponsors by registered trial count).
University of California, San Diego: 775 sponsored US clinical trials, 143 recruiting.
University of California, San Diego sponsors 775 registered US clinical trials on ClinicalTrials.gov, 143 of them currently recruiting, and 499 completed. 104 of these trials are in Phase 3-4 (later-stage) and 170 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Anorexia Nervosa, with 10 trials.
Top-decile sponsor footprint
University of California, San Diego ranks in the top decile of sponsors by registered trial count (#43 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
499 of 553 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (90.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
775 total, page 7 of 16
Optimizing Post-operative Recovery in Bariatric Patients With Obstructive Sleep Apnea Undergoing Outpatient Surgery: A Comparison of Sugammadex and Neostigmine
NCT04570150
MIP Versus PCNL for Kidney Stone Disease
NCT04767919
Chronic Low Back Pain and Meditation
NCT04034004
MIS-C Comparative Effectiveness Study
NCT04898231
Combination Drug-Therapy for Patients With Untreated Obstructive Sleep Apnea
NCT04639193
Efficacy of Inhaled Cannabis for Acute Migraine Treatment
NCT04360044
Pharmacologic Augmentation of Targeted Cognitive Training in Schizophrenia
NCT04414930
Clinical Feasibility of a Conformal Ultrasound Blood Pressure Sensor
NCT05909605
Dopamine Receptor Contributions to Prediction Error and Reversal Learning in Anorexia Nervosa
NCT04128683
Renal Effects of Hormones/Biomarkers in Transgender PrEP Recipients
NCT04742816
Physical Activity Intervention for Adolescent Girls
NCT04190225
Fludarabine in Combination With Daunorubicin and Cytarabine Liposome in Newly-diagnosed Acute Myeloid Leukemia.
NCT04425655
Characterization of Multisystem Inflammatory Syndrome in Children (MIS-C) and Its Relationship to Kawasaki Disease
NCT04538495
Gabapentin and Tizanidine for Insomnia in Chronic Pain
NCT04429347
Glutathione-rich Foods for Type 2 Diabetes
NCT04386187
Perineural Local Anesthetic Administration With a Continuous Infusion Versus Automatic Intermittent Boluses
NCT04458467
Binge Eating Anxiety and Mood
NCT04242550
Weighted Blankets and Chronic Pain
NCT04447885
Addition of Buprenorphine to Paracervical Block for Pain Control During Osmotic Dilator Insertion
NCT04254081
Instacare - Rapid ART Initiation Among Persons With HIV and Out of Care
NCT04240691
Ramipril for the Treatment of COVID-19
NCT04366050
Tadalafil and Pembrolizumab in Recurrent or Metastatic Head and Neck Cancer
NCT03993353
Rib Fracture Analgesia Using Cryoanalgesia
NCT04198662
Gynecologic Brachytherapy-Specific Educational Video
NCT04363957
Mindfulness and Chronic Low Back Pain
NCT03354585
The BRIDGES Project: Bridging Resources to Engage Women in Integrated HIV Care and Support Services
NCT04295876
PSG Validation Study of Zensorium Biosensing Wearable Device
NCT04200495
Access to Tailored Autism Integrated Care Pilot Study
NCT04293627
Neurotherapeutics as an Adjunctive Approach to Enhance Exposure Outcomes in Anxiety
NCT04953832
FRESH-TEEN: Families Responsibility Education Support Health for Teens
NCT03674944
Physical Activity Intervention for Young Cancer Survivors
NCT04064892
Novel Pharmacotherapy Approaches in Smokers With Serious Mental Illness
NCT04011280
Accuracy Comparison of Two CGMs in Hospitalized Patients
NCT05081817
Transoral Daytime Neuromuscular Electrical Stimulation in Patients With Simple Snoring
NCT03913494
Stem Cell Gene Therapy for Cystinosis
NCT03897361
Safety and Efficacy of Deoxycholic Acid Injection for Reduction of Upper Inner Thigh Fat
NCT04054011
Lumbar Spine Muscle Degeneration Inhibits Rehabilitation-Induced Muscle Recovery
NCT03442374
Metabolic Pathways of GRA in Patients With Type 1 Diabetes
NCT03919617
PACIFIC-FIT: Providing Adults Collaborative Interventions for Ideal Changes Focused Intervention and Tracking
NCT03914508
Pilot Study of Atorvastatin and Anakinra in Children With Coronary Artery Abnormalities Secondary to Kawasaki Disease
NCT04747847
Novel Executive Function Training for Obesity
NCT03724396
2nd AC+: New Village Model
NCT04323176
Comparative and Additive Diagnostic Performance of Magnetic Resonance Elastography (MRE) and Corrected-T1 (cT1) for Fibrosis and Inflammation in Nonalcoholic Steatohepatitis (NASH) Using Histology As Reference
NCT04389593
DHFS for Medication Adherence Support During Hospital Admissions for Person Living With HIV
NCT04418037
Serratus Plane Versus Paravertebral Nerve Blocks for Breast Surgery
NCT03860974
Measuring Plasticity in SFC/dACC Following Theta-Burst-Stimulation Using TMS
NCT03946059
Intercostal Cryoneurolysis Following Traumatic Rib Fractures
NCT03917823
Somatization, Anxiety, and Disordered Sleep in Pediatric Eosinophilic Esophagitis
NCT04309786
SMART 2.0: Social Mobile Approaches to Reducing weighT in Young Adults
NCT03907462
Mobile CBT for Negative Symptoms
NCT03621774
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 80 |
| Phase 2 | 90 |
| Phase 3 | 22 |
| Phase 4 | 82 |
Therapeutic Areas
What is open in the University of California, San Diego pipeline
143 recruiting of 775 indexed (18% open); 499 completed (64%).
Phase mix: 104 late (III/IV) vs 170 early (I/II) (early-phase heavy).
Top condition: Anorexia Nervosa (10 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of California, San Diego: open-pipeline peers nationwide
Peers matched on 775 registered trials and 18% open enrollment, not the therapeutic-area sidebar.
University of California, San Diego sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 775 trials (± recruiting share)
- Dana-Farber Cancer Institute · 781 trials · 14% recruiting
- Medical University of South Carolina · 755 trials · 19% recruiting
- University of Chicago · 796 trials · 20% recruiting
- University of Utah · 818 trials · 17% recruiting
Sponsors near 18% open enrollment (± trial volume)
- Neurocrine Biosciences · 18% recruiting · 65 trials
- Thomas Jefferson University · 18% recruiting · 292 trials
- Abramson Cancer Center at Penn Medicine · 18% recruiting · 402 trials
- University of Maryland, Baltimore · 18% recruiting · 560 trials
Related
What to do with this University of California, San Diego page
775 registered trials is a research-attention snapshot, not an endorsement of University of California, San Diego or any single study.
- 143 of University of California, San Diego's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Anorexia Nervosa is the condition University of California, San Diego studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Anorexia Nervosa trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of California, San Diego pipeline card: 775 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.